14 smaller drug makers’ earnings halves in 1Q

Published: 2012-05-17 06:59:00

Updated: 2012-05-17 06:59:00

Influenced by the government’s intensive campaign to prevent illegal kickbacks, 14 smaller companies with less than 100 billion won in sales saw their earnings shrink almost 50 percent in the first three months of fiscal 2012, the data revealed on Monday.

These companies include Kyungdong Phar...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK